Discoveries made over the last two decades have established that the nervous system produces opioid peptides, as well as several classes of opioid receptors coupled to intracellular effectors. It is likely that either endogenous or exogenous opioids interact with these receptors, although the physiological circumstances which lead to occupancy of receptors by endogenous opioids is far from clear. It is generally assumed that endogenous opioids are delivered to opioid receptors by cellular - arrangements and mechanisms similar to those established for classical neurotransmitters, that is, at a synapse. However, several observations suggest that the classical form of synaptic transmission may not hold for neuropeptides in general, and opioid peptides in particular. The overall goal of studies in this laboratory is to determine at the cellular level the spatial organization of the molecules functionally involved in opioid neurotransmission. This goal will be approached through experiments designed to investigate the following specific aims: 1) To determine the spatial relationship of nerve terminals which contain opioid peptides to specific regions of the dendritic tree and cell body of target neurons; 2) To determine the spatial distribution of opioid receptors within the membrane of the dendritic tree and cell body of """"""""opioceptive"""""""" neurons. For certain neurons, the distribution of these receptors observed under physiological conditions will be compared with the distribution of receptors under the conditions usually employed in """"""""binding"""""""" studies; 3) To determine the spatial distribution of G-proteins predicted to mediate opioid action within the membrane of the dendritic tree and cell body of opioceptive neurons; 4) To determine the spatial relations among the three features outlined above. In particular, the proximity of opioid nerve terminals to opioid receptors will be determined, as will the relationship between opioid receptors and G-proteins. The latter relationship will also be examined under conditions thought to increase or decrease G-protein/receptor coupling. In order to accomplish some of these aims, we propose the synthesis of new, highly fluorescent ligands for opioid receptors. These ligands will be designed not only for their ability to bind selectively to classes of opioid receptors, but also to exploit the imaging power of scanning laser confocal microscopy. Knowledge gained from these studies will determine if opioidergic neurotransmission obeys the organizational 'rules' proposed to exist for synaptic transmission. If opioidergic nerve terminals and opioid receptors are not compartmentalized as in a classical synapse, these studies will determine the cellular arrangements through which opioids act upon their targets.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37DA006299-04
Application #
3482689
Study Section
Special Emphasis Panel (SRCD (04))
Project Start
1990-03-01
Project End
1995-02-28
Budget Start
1993-03-01
Budget End
1994-02-28
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Stone, Laura S; Vulchanova, Lucy; Riedl, Maureen S et al. (2004) Effects of peripheral nerve injury on delta opioid receptor (DOR) immunoreactivity in the rat spinal cord. Neurosci Lett 361:208-11
Stone, L S; Vulchanova, L; Riedl, M S et al. (1999) Effects of peripheral nerve injury on alpha-2A and alpha-2C adrenergic receptor immunoreactivity in the rat spinal cord. Neuroscience 93:1399-407
Stone, L S; Broberger, C; Vulchanova, L et al. (1998) Differential distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord. J Neurosci 18:5928-37
Arvidsson, U; Dado, R J; Riedl, M et al. (1995) delta-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J Neurosci 15:1215-35
Arvidsson, U; Riedl, M; Chakrabarti, S et al. (1995) The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids. Proc Natl Acad Sci U S A 92:5062-6
Arvidsson, U; Riedl, M; Chakrabarti, S et al. (1995) Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci 15:3328-41
Elde, R; Arvidsson, U; Riedl, M et al. (1995) Distribution of neuropeptide receptors. New views of peptidergic neurotransmission made possible by antibodies to opioid receptors. Ann N Y Acad Sci 757:390-404
Wu, W; Elde, R; Wessendorf, M W (1993) Organization of the serotonergic innervation of spinal neurons in rats--III. Differential serotonergic innervation of somatic and parasympathetic preganglionic motoneurons as determined by patterns of co-existing peptides. Neuroscience 55:223-33
Calza, L; Giardino, L; Ceccatelli, S et al. (1992) Distribution of thyrotropin-releasing hormone receptor messenger RNA in the rat brain: an in situ hybridization study. Neuroscience 51:891-909
Lane, C M; Elde, R; Loh, H H et al. (1992) Regulation of an opioid-binding protein in NG108-15 cells parallels regulation of delta-opioid receptors. Proc Natl Acad Sci U S A 89:11234-8

Showing the most recent 10 out of 13 publications